US FDA’s Prasad: ‘We Will Always Embrace Surrogate Endpoints’

Vinay Prasad
CBER Director Vinay Prasad discussed accelerated approval and cancer with FDA Commissioner Martin Makary after a 20 May presentation. (US FDA webstream)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from R&D